Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 17;22(6):121.
doi: 10.1208/s12248-020-00506-4.

Pulmonary administration of remdesivir in the treatment of COVID-19

Affiliations
Comment

Pulmonary administration of remdesivir in the treatment of COVID-19

Henrik Berg Rasmussen et al. AAPS J. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Sun D. Remdesivir for treatment of COVID-19: combination of pulmonary and IV administration may offer additional benefit. AAPS J. 2020;22:77. doi: 10.1208/s12248-020-00459-8. - DOI - PMC - PubMed
    1. Buss N, Cammack N. Measuring the effectiveness of antiretroviral agents. Antivir Ther. 2001;6:1–7. - PubMed
    1. Arshad U, Pertinez H, Box H, Tatham L, Rajoli RKR, Curley P, et al. Prioritization of anti-SARS-Cov-2 drug repurposing opportunities based on plasma and target site concentrations derived from their established human pharmacokinetics. Clin Pharmacol Ther. 2020. 10.1002/cpt.1909. - PMC - PubMed
    1. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. doi: 10.1038/s41422-020-0282-0. - DOI - PMC - PubMed
    1. Pruijssers AJ, George AS, Schäfer A, Leist SR, Gralinksi LE, Dinnon KH, et al. Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep. 2020;107940. - PMC - PubMed

LinkOut - more resources